Insurers that want to sell plans through the federal exchanges for 2015 would have to do more to ensure members have access to an adequate network of providers.
The U.S.Department of Health and Human Services (HHS) ruled in February that laboratories are allowed to give patients or their designated representative a means of direct access to the patients’ completed test reports upon their request.
A new study has found that patients who skip an antibiotic often used by hospitals to combat infection during patients’ stays and prescribed to continue that fight after discharge are more likely to return to the hospital.
Physicians will need to be on the outlook for a number of deadlines pertaining to quality of care, electronic health records and coding in 2014 coming from the Centers for Medicare and Medicaid Services, as well as a result of the Affordable Care Act.
The success of the newly operational state health insurance exchanges depends heavily on insuring healthy, young adults to balance the risk of covering older, less healthy consumers.
In September 2013, the U.S. Food and Drug Administration (FDA) awarded $3.5 million in grants to enhance the availability and development of medical devices for children.
Updates about SynCon(R) DNA vaccine, melanoma vaccine and Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted.
Two types of environmental conditions — cold-dry and humid-rainy — are associated with seasonal influenza epidemics, according to an epidemiological study led by researchers at the National Institutes of Health’s Fogarty International Center.
Grifols has launched the SPIRIT(Study of Plasma-derived factor VIII/VWF in Immune toleRance Induction Therapy) registry for patients with hemophilia A.
The U.S. Food and DrugAdministration has approved obinutuzumab (Gazyva, Genentech)for the treatment of patients with previously untreated chronic lymphocyticleukemia.
Researchers at the Sealy Center forVaccine Development at the University of Texas Medical Branch (UTMB) at Galveston have developed a safe vaccine candidate for Chagas disease that is simple to produce and shows a greater than 90 percent protection rate against chronic infection in mice.
